CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 35,417 shares (grant or award)
- 4 Grant or award Director acquired 37,689 shares (grant or award)
- 4 Grant or award Director acquired 37,500 shares (grant or award)
- 4 Grant or award Director acquired 45,455 shares (grant or award)
- 4 Open-market buy Director bought 34,848 shares
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 30,000 shares at $1.00 ($30,000)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.57 ($14,250)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Chief Financial Officer bought 75,000 shares at $0.61 ($45,750)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 28 of 78 · 1,549 filings